RLAY - Relay Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$23.00
DETAILS
HIGH:
$27.00
LOW:
$18.00
MEDIAN:
$22.00
CONSENSUS:
$23.00
UPSIDE:
69.99%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 76.8% |
| EBIT Margin | -1800.6% |
| EBITDA Margin | -1777.4% |
| Operating Margin | -1971.6% |
| Pretax Margin | -1800.6% |
| Cont. Ops Margin | -1800.6% |
| Net Margin | -1800.6% |
| Bottom Line Margin | -1800.6% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 22.61 |
| Quick Ratio | 22.61 |
| Solvency Ratio | -5.029 |
| Cash Ratio | 3.28 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-5.25
Peers avg: 36.2
|
| PEG Ratio | 0.17 |
| Forward PEG | 0.17 |
| Price/Book | 2.56 |
| Price/Sales | 94.54 |
| Price/FCF | -6.15 |
| Price/Op Cash Flow | -6.17 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0522 |
| Debt/Equity | 0.0572 |
| Debt/Capital | 0.0541 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.10 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.02 |
| Operating Cash Flow Ratio | -9.205 |
| Operating Cash Flow/Sales | -1533.4% |
| Free Cash Flow/Operating Cash Flow | 100.2% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -72.49 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -62.54 |
| Operating Cash Flow Coverage | -7.25 |
| Capital Expenditure Coverage | -574.28 |
| Dividend + Capital Expenditure Coverage | -574.28 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.09 |
| EPS | -1.611 |
| Debt/Share | 0.1892 |
| Cash/Share | 3.23 |
| Book Value/Share | 3.30 |
| Tangible BV/Share | 3.30 |
| Equity/Share | 3.30 |
| Operating Cash Flow/Share | -1.372 |
| Capital Expenditure/Share | 0.002 |
| FCF/Share | -1.375 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.913 |
| Price/Fair Value | 2.56 |
| Debt/Market Cap | 0.0026 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -5.13 |